These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12401197)

  • 41. Competitive inhibition of lipolytic enzymes. VII. The interaction of pancreatic phospholipase A2 with micellar lipid/water interfaces of competitive inhibitors.
    Deveer AM; Franken PA; Dijkman R; Meeldijk J; Egmond MR; Verheij HM; Verger R; de Haas GH
    Biochim Biophys Acta; 1992 Apr; 1125(1):73-81. PubMed ID: 1567910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of phospholipase A2 with different localization in liposomes.
    Karmalita EG; Serebrov VY; Novitskii SV; Novitskaya TV; Vavilkin DA
    Bull Exp Biol Med; 2002 Sep; 134(3):251-3. PubMed ID: 12511994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
    Andresen TL; Jensen SS; Jørgensen K
    Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phospholipase A2 domain formation in hydrolyzed asymmetric phospholipid monolayers at the air/water interface.
    Maloney KM; Grandbois M; Grainger DW; Salesse C; Lewis KA; Roberts MF
    Biochim Biophys Acta; 1995 May; 1235(2):395-405. PubMed ID: 7756350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lysine-49-phospholipases A2 from Trimeresurus flavoviridis venom are membrane-acting enzymes.
    Shimohigashi Y; Tani A; Matsumoto H; Nakashima K; Yamaguchi Y
    J Biochem; 1995 Nov; 118(5):1037-44. PubMed ID: 8749324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipid ozonation products activate phospholipases A2, C, and D.
    Kafoury RM; Pryor WA; Squadrito GL; Salgo MG; Zou X; Friedman M
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):338-49. PubMed ID: 9653065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential interfacial and substrate binding modes of mammalian pancreatic phospholipases A2: a comparison among human, bovine, and porcine enzymes.
    Snitko Y; Han SK; Lee BI; Cho W
    Biochemistry; 1999 Jun; 38(24):7803-10. PubMed ID: 10387020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interfacial catalysis by phospholipase A2: monomeric enzyme is fully catalytically active at the bilayer interface.
    Jain MK; Ranadive G; Yu BZ; Verheij HM
    Biochemistry; 1991 Jul; 30(29):7330-40. PubMed ID: 1854741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of sporidesmin, a mycotoxin from Pithomyces chartarum, with lipid bilayers.
    Upreti GC; Jain MK
    Biosci Rep; 1993 Aug; 13(4):233-43. PubMed ID: 8305634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atomic force microscope visualization of lipid bilayer degradation due to action of phospholipase A2 and Humicola lanuginosa lipase.
    Balashev K; John DiNardo N; Callisen TH; Svendsen A; Bjørnholm T
    Biochim Biophys Acta; 2007 Jan; 1768(1):90-9. PubMed ID: 17084807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane structure, toxins and phospholipase A2 activity.
    Vernon LP; Bell JD
    Pharmacol Ther; 1992; 54(3):269-95. PubMed ID: 1465478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzymatic degradation of polymer covered SOPC-liposomes in relation to drug delivery.
    Davidsen J; Vermehren C; Frøkjaer S; Mouritsen OG; Jørgensen K
    Adv Colloid Interface Sci; 2001 Jan; 89-90():303-11. PubMed ID: 11215800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of bee venom phospholipase A2 through a peptide-enzyme complex.
    Mingarro I; Pérez-Payá E; Pinilla C; Appel JR; Houghten RA; Blondelle SE
    FEBS Lett; 1995 Sep; 372(1):131-4. PubMed ID: 7556634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A liposomal hydrogel with enzyme triggered release for infected wound.
    Li D; An X; Mu Y
    Chem Phys Lipids; 2019 Sep; 223():104783. PubMed ID: 31233714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular details of the activation of soluble phospholipase A2 on lipid bilayers. Comparison of computer simulations with experimental results.
    Bell JD; Biltonen RL
    J Biol Chem; 1992 Jun; 267(16):11046-56. PubMed ID: 1597446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fabrication of liposomal doxorubicin exhibiting ultrasensitivity against phospholipase A
    Tagami T; Ando Y; Ozeki T
    Int J Pharm; 2017 Jan; 517(1-2):35-41. PubMed ID: 27865984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of human secretory class II phospholipase A2 by heparin.
    Dua R; Cho W
    Eur J Biochem; 1994 Apr; 221(1):481-90. PubMed ID: 8168536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzyme activity to augment the characterization of tethered bilayer membranes.
    Valincius G; McGillivray DJ; Febo-Ayala W; Vanderah DJ; Kasianowicz JJ; Lösche M
    J Phys Chem B; 2006 Jun; 110(21):10213-6. PubMed ID: 16722717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of phospholipase A2 from Naja melanoleuca snake venom with monomeric substrate analogs. Activation of the enzyme by protein-protein or lipid-protein interactions?
    van Eijk JH; Verheij HM; Dijkman R; de Haas GH
    Eur J Biochem; 1983 Apr; 132(1):183-8. PubMed ID: 6840082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergism between mellitin and phospholipase A2 from bee venom: apparent activation by intervesicle exchange of phospholipids.
    Cajal Y; Jain MK
    Biochemistry; 1997 Apr; 36(13):3882-93. PubMed ID: 9092818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.